Official Online Store

MENU

Euglena newsNews

Press Releases

* Please note that the news release contains the content at the time of the announcement and may differ from the latest information.

2019.07.30

Euglena!" Will begin airing on August 1st (Thursday)!
Introducing the results of human clinical trials of Euglena
-Broadcast commercials in Hiroshima, Okayama, Kagawa, and Okinawa areas-

Euglena Co., Ltd.

 Euglena Co., Ltd. (Headquarters: Minato-ku, Tokyo, President: Mitsuru Izumo) is a terrestrial television CM that introduces the results of human clinical trials to raise awareness of Euglena Euglena!" Will be broadcast from Thursday, August 1st in the Hiroshima, Okayama, Kagawa, and Okinawa areas.
 This CM was announced at the 73rd Japan Society of Nutrition and Food Science Euglena effectively contributes to the state of the brain (elevation of brain-derived neurotrophic factor BDNF, cognitive function speed and exercise speed). It is a content that explains in an easy-to-understand manner (improvement, improvement of mental health score).

Suzuki-san 〆 shot

CM image

■ CM Story (Research and Development Suzuki ver.)
"New discovery in microalgae Euglena!" Explains Suzuki (Doctor of Medicine), Executive Officer in charge of research and development.

Figure 2

Graphs explain test results such as "elevation of BDNF, a protein essential for increasing brain cells," "improvement of information processing ability of the brain," and "improvement of mental health score."

Graph

Finally, an easy-to-understand "and head, the body, Euglena.", And "Euglena will guide you through the site you can see slowly with the test results search! In the lab."

Figure 2

「代表取締役社長ver.」や「研究メンバー ver.」なども放送予定です。

Figure 3
■ "New discovery in Euglena
Researcher "Multi-function" (30 seconds) https://youtu.be/7T61daWv8hQ
Free study "Brain & Health Score" (30 seconds) https://youtu.be/-IizBkN11RE etc.

■ Broadcast area
Hiroshima area, Okayama area, Kagawa area, Okinawa area

■ Broadcast period
August 1, 2019 (Thursday) -August 14, 2019 (Wednesday)
August 22, 2019 (Thursday) -August 31, 2019 (Saturday)

■ About human clinical trial results
We confirmed that continuous intake of the microalgae Euglena effectively contributes to the state of the brain.
(Applicable release: https://euglena.jp/news/20190528/)
・ BDNF in blood, a protein essential for increasing brain cells * Rise
 * BDNF is known to decrease in dose in patients with Alzheimer's disease and depression.
・ Improvement of body movement speed (cognitive function speed / exercise speed) by command from the brain
・ Improvement of mental health score as health-related QOL (quality of life)

<About Euglena Co., Ltd.>
In 2005, we succeeded in establishing the world's first edible outdoor mass culture technology for the Euglena In Euglena and Chlorella, we are also conducting research toward the production of biofuels. Euglena GENKI Program, which has been in operation since 2014 to deliver Euglena cookies with abundant nutrients to children in Bangladesh, will be expanded to all group products including cosmetics from April 2019. Listed on TSE Mothers in December 2012. TSE First Section market change in December 2014. The management philosophy is "to make people and the earth healthy". https://euglena.jp

​ ​

-Contact for inquiries from the press-
Euglena Co., Ltd. Corporate Communication Division

Return to top of page

This website uses cookies to acquire and use access data for the purpose of improving the experience on the site.
When using this site, please agree to the use of cookies.
Please see the "Privacy Policy" for information on site cookies.

agree